Cite

HARVARD Citation

    Florescu, D. et al. (2014). Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses. Expert review of anti-infective therapy. 12 (10), pp. 1171-1178. [Online]. 
  
Back to record